CHINA GEWANG BIOTECHNOLOGY, INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
CHINA GEWANG BIOTECHNOLOGY, INC. reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $88.82 thousand for the 9-month period ending 2016-08-31, per its 10-Q filed 2016-10-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2016-10-14
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2016-08-31 was $36.63K, a 134.52% increase year-over-year.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2016-05-31 was $32.19K, a 109.30% increase year-over-year.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2016-02-29 was $20.00K, a 21.31% decline year-over-year.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2015-11-30 was $274.52K.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2015 was $330.94K, a 3416.85% increase from fiscal 2014.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2014 was $9.41K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|---|
| 2016-08-31 | $36.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-14 | $68.82K derived: sum of 2 quarters · filed 2016-10-14 | $88.82K 10-Q · filed 2016-10-14 | $363.34K derived: sum of 4 quarters · filed 2016-10-14 | |
| 2016-05-31 | $32.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-15 | $52.19K 10-Q · filed 2016-07-15 | $326.71K derived: sum of 3 quarters · filed 2016-07-15 | $342.33K derived: sum of 4 quarters · filed 2016-10-14 | |
| 2016-02-29 | $20.00K 10-Q · filed 2016-04-15 | $294.52K derived: sum of 2 quarters · filed 2016-04-15 | $310.14K derived: sum of 3 quarters · filed 2016-10-14 | $325.52K derived: sum of 4 quarters · filed 2016-10-14 | |
| 2015-11-30 | $274.52K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $290.14K derived: sum of 2 quarters · filed 2016-10-14 | $305.52K derived: sum of 3 quarters · filed 2016-10-14 | $330.94K 10-K · filed 2016-02-29 | |
| 2015-08-31 | $15.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-14 | $31.00K derived: sum of 2 quarters · filed 2016-10-14 | $56.41K 10-Q · filed 2016-10-14 | ||
| 2015-05-31 | $15.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-15 | $40.80K 10-Q · filed 2016-07-15 | $28.80K 10-Q · filed 2015-07-22 | ||
| 2015-02-28 | $25.42K 10-Q · filed 2016-04-15 | ||||
| 2014-11-30 | $9.41K 10-K · filed 2016-02-29 |